Ochsner Health
Ochsner Health System Formulary
Formulary Addition Request
Questions or Suggestions?
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
HazD
Look Alike Sound Alike
Ambulatory
Do Not Crush
REMS
IV Push Administration
Vaccine
SDS Online
Do Not Crush
OHS Pharmacy Contact
Louisiana Poison Control(800) 222-1222
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Ochsner Health COVID-19 SharePoint Site
"Safety On Site"
Click here
to enter an S.O.S.
Physician
Nurse
Partners
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local
pharmacy
for available inventory.
Ochsner Health
Ochsner Health System Formulary
Formulary Addition Request
Questions or Suggestions?
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
HazD
Look Alike Sound Alike
Ambulatory
Do Not Crush
REMS
IV Push Administration
Vaccine
SDS Online
Do Not Crush
OHS Pharmacy Contact
Louisiana Poison Control(800) 222-1222
Webpage Links
Search results for:
faricimab ophthalmic
faricimab ophthalmic
Drug Name
Form
Strength
Infusion Center Available
Restricted
Non-formulary
Ambulatory Available
Interchange
REMS
Vabysmo
SOLUTION, INTRAVITREAL
svoa 6 mg/0.05 mL
VIEW MORE
Vascular Endothelial Growth Factor Antagonists
CLASS
525600
Additional Information and Links
Restricted to:
Service
Line: Ophthalmology
Formulary
Location: Outpatient/Ambulatory
Service
location:
Ophthalmology
Clinics
Patient Population: Adult
Prior
Authorization Required: Yes
Restriction/Criteria
of
Use
(all
will
apply
unless
specified):
Tried
and
failed,
intolerant,
or
contraindicated
to
intravitreal
bevacizumab
(Avastin)
Will not be used concurrently with other ophthalmic VEGF inhibitors (e.g., aflibercept (Eylea), ranibizumab (Lucentis), bevacizumab (Avastin))
Patient
does
not
have
uncontrolled
glaucoma
and/or
active
ocular inflammation
For
women
of
childbearing
potential:
Negative
pregnancy
test
prior
to
the
treatment
Last updated:
Feb. 10, 2023
UpToDate
Lexicomp
DailyMed Package Inserts
Johns Hopkins Guides
Restricted to: